多替阿巴拉米片在那里买

(Suimeikai) is a new fixed-dose compound preparation against human immunodeficiency virus (HIV) infection containing three ingredients: dolutegravir, abacavir and lamivudine. Dolutegravir (Suimeike) is suitable for the treatment of HIV infection in adults and adolescents aged 12 years and above. Current drugs for the treatment of AIDS have shortcomings such as high incidence of adverse reactions, poor tolerance, and many drug interactions, and there is the possibility of drug resistance after long-term medication. Doptabalamid Tablets (Suimeike) has certain clinical advantages over existing treatment options, adding new treatment options to the clinic.

Dolutea Abalamid Tablets (Sumeikat) was approved for marketing in 2014, and it took only two years to reach the top of the global AIDS drug sales rankings. On January 20, 2018, Dolutea Abalamid Tablets (Sumeikat) entered the Chinese mainland market as the first single-piece compound preparation. This is the best-selling AIDS drug in the world in the past five years, and it is also an important part of GSK China's AIDS field in recent years.

Where can I buy Abalami Tablets?

Docetabalamid Tablets (Suimeikai) have been launched in China, and patients can purchase the drug at major domestic regular pharmacies or hospital pharmacies with a prescription issued by a doctor. It is understood that the Abalami tablets (Suimeike) produced by Emcure in India are cost-effective, with a specification of 30 tablets and a price of about $1,000. Since the exchange rate floating price is not fixed, if patients want to know the specific price information of Dolutea Paramid Tablets (Suimeike), or want to purchase the drug overseas, they can consult the medical companion travel service.

(Suimeikan) cannot be used for individuals who carry the HLA-B*5701 gene. Patients carrying this gene will have a high risk of severe hypersensitivity reactions (type I allergic reactions) when using Suimeikan. Therefore, before taking Doptabalamid Tablets (Suimeike), you need to complete the test to determine whether you carry the special type of "HLA-B*5701" gene.

Recommended related hot articles: /newsDetail/85387.html